Total sales of $81.6 million, up 21.2%, driven by strong sales in key product
•
categories, new product releases and the normalising of most dental
markets.
•
Total operating expenses increased by 1.2%, compared to the previous
corresponding period.
•
EBITDA up 71.9% to $16.8m (FY20: $9.8m)
•
NPAT up 111.2% to $8.9m (FY20: $4.2m)
use•
Cashflow remains strong, with no net debt for the Group.
•
Final fully franked dividend of 1.65cps up 230% on pcp with full year ordinary
ersonal
dividends of 3.15cps equating to a payout ratio of 41.9%.
•
The Brazilian operations review was completed in the year, with the
restructure expected to be fully implemented by January 2022.
•
Study released showing that SDI's Riva Star product stops decay, reducing
the number of children requiring general anaesthetics for tooth extraction*
*International Dental Journal - May 2021- Dr Rana Yawary
EBITDA($m)
16.8
14.2
12.5
12.1
8.3
7.8
9.8
7.6
8.6
2.7
8.5
6.4
7.1
4.9
3.6
FY17
FY18
FY19
FY20
FY21
H1 ($m)
H2 ($m)
SALES ($m)
74.1
74.5
79.6
67.4
81.6
39.7
40.9
42.5
27.4
44.8
34.4
33.6
37.1
40.0
36.8
FY17
FY18
FY19
FY20
FY21
H1 ($m)
H2 ($m)
CATEGORY OVERVIEW
DOUBLE DIGIT CAGR IN KEY FOCUS PRODUCTS
ersonal use only
Whitening showed the strongest increase, up 55.3% in local currency, due to a return of strong demand, the release of a new Pola Light and Pola Rapid products and the rebranding of the range.
Aesthetics recovered strongly on the previous year, up 27.2% in local currency, assisted by the easing of restrictions on dentists.
Equipment up 31.1% in local currency, driven primarily by the success of the Radii LED curing lights.
Amalgam products stabilised, up 3.8% in local currency with the North American market offsetting declines in other regions.
Product Mix %
Aesthetics
Whitening
Equipment
Amalgam
15.3%
29.9%
26.1%
23.0%
19.6%
7.3%
7.6%
7.6%
8.3%
8.6%
26.9%
32.5%
26.7%
27.0%
26.2%
35.2%
38.9%
42.4%
45.9%
44.9%
FY17
FY18
FY19
FY20
FY21
ersonal use only
FULL PRODUCT PIPELINE
PROMISING SIGNS FOR AMALGAM REPLACEMENT
Amalgam replacement release in 2022/23:
Tooth coloured filling, showing strength stronger than amalgam
Stronger than any other tooth coloured filling material
Will be able to withstand high mastication forces
New composite products upgrading Luna composite line scheduled for early 2022 release.
Committed to 1-2 products per year.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
SDI Limited published this content on 18 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 November 2021 23:32:08 UTC.
SDI Limited is an Australia-based company that is involved in the research and development, manufacturing, and marketing of specialist dental materials. The principal activities of the Company include manufacture and distribution of dental restorative materials, whitening systems, other dental materials and product research and development. Its segments include Australia, Europe, USA, and Brazil. Australia segments include SDI Limited. The Europe segment include SDI Germany GmbH (Germany) and SDI Dental Innovations Limited (United Kingdom). The USA segment includes SDI (North America), Inc. The Brazil segment includes SDI Brasil Industria e Comercio Ltda and SDI Holdings Do Brazil Ltda. Its product categories include accessories, adhesives, alloys, cements, composites, equipment, etchants, glass ionomers, sealants, and tooth whitening. Its products are sold through distributors and retailers in over 100 countries throughout the world.